|
|
Article: Consumer Groups File Brief to Prevent Withdrawal of Generic BuSpar(R), According to Stop Patient Abuse Now; 50 Groups in 19 States Ask Court to Stop Bristol-Myers Squibb Effort.
- Article from:
- PR Newswire
- Article date:
- December 4, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- Fifty members of the Stop Patient Abuse Now coalition today submitted a brief to a federal court of appeals to support the right of drug makers to continue marketing generic versions of the anxiety drug BuSpar.
An appeals court ruled in October that a lower court should not have ordered the de-listing of a patent Bristol-Myers Squibb used to prevent sales of generic BuSpar. The court ruled that, despite a lower court's finding that the patent was frivolous and unlawfully listed, a generic drug manufacturer that requested the de-listing did not have proper legal standing to initiate the court action. The new ruling may allow Bristol to demand that ...
Related newspaper, magazine, and journal articles:
|
|
Article: Gray Panthers discuss ways to improve health care
University Wire;
June 17, 2002 ;
685 words
... ... Saturday. Who Lives, Who Pays, Who Dies was organized by the Gray Panthers, a senior citizens' advocacy group. About 100 people attended ... said. You will be able to see that in the county budget. New York physician Rudolf Mueller spoke of his experiences while writing ...
|
|